Abiopharma

IBOTTA, INC. (IBTA) Reports the reporting period Financial Results IBOTTA, INC. (IBTA) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 88905
• Net Income: 0.46
• EPS: Not disclosed
• Cash and equivalents: 148173
  • Ibotta offers became available to Uber customers during the quarter with the overall program expected to ramp in the coming months.
  • Subsequent to quarter
  • end, Ibotta offers became available to Giant Eagle customers.
    • anticipated in the forward-looking statements as a result of numerous factors, many of which are beyond the control of the Company. These and other factors are disclosed in the Company’s annual and quarterly reports filed from time to time with the Securities and Exchange Commission, available at www.sec.gov. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company does not intend to update any forward-looking statement contained in this press release to reflect events or circumstances arising after the date hereof, except as required by law.Ibotta, Inc.CONDENSED STATEMENTS OF OPERATIONS (In thousands, except share and per share amounts)(unaudited)Three months ended June 30,Six months ended June 30,2026